Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin-A for Hidradenitis Suppurativa
NCT06237465Phase 4Withdrawn
- Sponsor
- Yale University
- Start
- Jan 2025
- Primary completion
- Jun 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in hidradenitis suppurativa (HS), sponsored by Yale University. Planned start Jan 2025; status: withdrawn.
02
Drugs
botulinum toxin type A
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on NCT06237465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06237465.